Aims to be a Global Leader in Cell Therapy

Innovative Cellular Therapeutics (ICTTM) was founded in August 2009 by Dr. Xiao Lei, winner of the China National Science Fund for Distinguished Young Scholars. ICTTM is positioned to become a global leader in cell therapy and committed to improving human health through vigorous scientific & technological innovation.  

In the field of cell therapy, stem cells and gene editing, ICTTM has reached international advanced level and has acquired more than 10 Chinese and international patents. The company is now recognized as one of the leading players in CAR-T cell therapy.


ICTTM provides pharmaceutical research and development in the pharmaceutical and biotechnology fields.